Keywords: hmr, amaryl, launched, uk, hoechst, marion, roussel
HMR's Amaryl Launched In UK
Article | 04 June 1998
Hoechst Marion Roussel has launched its new-generation sulfonylurea,Amaryl (glimepiride), in the UK for the once-daily treatment of non-insulin-dependent diabetes ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
